Beyond cosmetic concerns, injuries and medical procedures are central to demand in the scar treatment market. Polaris Market Research reports a market value of USD 2.94 billion in 2024, rising from USD 3.25 billion in 2025 to USD 8.24 billion by 2034 at a CAGR of 10.9%. The report segments the market by product, scar type, end use and region, with end-use categories covering hospitals, clinics and homecare.

Traumatic Scarring Expands the Patient Pool

The hypertrophic and keloid scars segment is expected to grow during the forecast period. The report attributes this to an increase in traumatic wounds, surgical procedures and burns, as well as rising accident cases. In North America, a high incidence of skin conditions, traumatic injuries and cosmetic concerns fuels demand, and according to the American Burn Association, the US alone records 450,000 serious burn injuries annually. The segmentation also covers contracture scars and stretch marks, the latter commonly resulting from pregnancy or weight fluctuations.

Asia Pacific and the Road Safety Factor

Asia Pacific is expected to experience significant growth. The increasing number of road accidents is leading to more traumatic injuries that result in scars, and demand for scar treatment is rising in countries such as India, China and Southeast Asia where such incidents are prevalent. According to the Indian Ministry of Road Transport and Highways, injuries from such incidents in India rose 15% in 2022 compared with 2021. People are increasingly seeking effective ways to manage and reduce accident-related scars. India's market is also expanding because of rising cases of skin conditions such as acne, greater awareness of cosmetic surgery, expanding healthcare infrastructure and rising disposable incomes.

Browse Full Insights:

https://www.polarismarketresearch.com/industry-analysis/scar-treatment-market

Surgical Trends and Technology

The growing adoption of minimally invasive surgeries is another driver. These procedures offer smaller incisions, a reduced risk of infection, less post-operative pain and faster recovery, and more patients are opting for them. According to the American Society of Plastic Surgeons, cosmetic procedures performed through less invasive techniques increased 19% in 2022 compared with 2019. Technology is improving outcomes and affordability as well, with microdermabrasion cited among the innovations that help improve healing, reduce scarring and offer faster recovery times.

Corporate Developments and Competition

Leading global corporations dominate the market by leveraging extensive research and development and advanced techniques, while new companies are impacting the industry by introducing innovative products to meet the demand of specific market sectors. In March 2025, Mölnlycke Health Care presented a study at the 35th European Wound Management Association Conference in Barcelona showing that moving chronic wound patients to Mepilex Border Flex, with enhanced clinician training, led to fewer dressing changes, reduced treatment costs and improved outcomes. Merz Pharmaceuticals is dedicated to advancing medical aesthetic treatments, and in April 2023, Merz Therapeutics finalized an asset purchase agreement with a US-based biotech firm, its second acquisition of a NASDAQ-listed company in over a decade. The high cost of tests and difficulties with reimbursement may reduce adoption of these products. Continuous progress in product offerings amplifies this competitive environment.

Key Players in the Scar Treatment Market

Established companies and new entrants compete through innovation in the market. Key players include:

•       Smith & Nephew PLC

•       Lumenis

•       CCA Industries, Inc.

•       Merz Pharmaceuticals

•       Mölnlycke Health Care AB

•       Sonoma Pharmaceuticals, Inc.

•       Newmedical Technology Inc.

•       Cynosure

•       Scar Heal Inc.

•       Pacific World Corporation

•       Perrigo Company plc

•       Enaltus LLC

Conclusion

Traumatic injuries, accident-related scarring in Asia Pacific and the shift toward less invasive surgery are widening demand for scar treatment as the market moves toward USD 8.24 billion by 2034. Providers and manufacturers that address both clinical and cosmetic needs across hospitals, clinics and homecare can strengthen their position in a market growing at a CAGR of 10.9%. North America led in 2024, while Asia Pacific is expected to experience significant growth.

More Trending Latest Reports By Polaris Market Research:

Gynecological Examination Chairs Market

Fluoropolymers Market

Safari Tourism Market

Enterprise Content Management Market

Automotive Ceramics Market

Mass Flow Controller Market

Hemophilia A Treatment Market

AI Trust, Risk and Security Management Market